Earnings call transcript: Ceres Power H1 2026 gains on cost cuts and pipeline growth

Ceres Power delivered approximately GBP 22.5 million of H1 2026 contracted revenue, reaching 50% of its unchanged GBP 45 million full-year target, while cutting R&D spending 28% year over year to GBP 18 million. An oversubscribed equity raise of more than GBP 100 million strengthened liquidity, and management expects to sign a new manufacturing licensee in 2026 with potential same-year revenue recognition. The Endura platform rollout and partner progress support the longer-term royalty opportunity, though Ceres remains loss-making and execution depends on partner factory buildouts, revenue timing and commercial adoption.

Analysis

CWR’s valuation hinge is not near-term license-fee delivery but the conversion of partner factory announcements into recurring royalty-bearing shipments. The equity raise removes immediate financing distress, yet it also raises the bar: cash-funded runway can mask whether the commercial model is self-sustaining. Because incremental partner capacity carries no additional license fee, each factory expansion improves CWR’s long-run royalty optionality but does not necessarily support the next 12 months’ reported revenue or cash flow.

The most investable second-order read is that CWR is a time-to-power beneficiary, but the economics remain exposed to regional spark spreads and natural-gas volatility. This makes Centrica (CNA) a potentially more direct demand-channel beneficiary in the UK/EU, while SHEL’s relevance is longer-dated hydrogen/electrolyzer optionality rather than a near-term earnings driver. NVDA benefits only indirectly: accelerated data-center power deployment can relieve a bottleneck to GPU cluster commissioning, but CWR is too small and early in the supply chain to alter NVDA estimates.

Over the next 1-3 months, confirmation of the back-half revenue conversion and a new manufacturing-license agreement are the principal catalysts; absence of either would expose the stock to de-rating because current results remain milestone-driven. The contrarian risk is that data-center buyers prefer proven gas turbines, reciprocating engines, or grid-plus-storage once supply normalizes, compressing CWR’s claimed scarcity premium before royalty scale arrives in 2027-29. Falsify the constructive view if FY contracted revenue slips, partner factory commissioning moves beyond 2026, or reported cash burn fails to decline despite the lower R&D base.

Key Decisions for Investors

• Maintain CWR as a small, event-driven long only after confirming liquidity and the correct London listing/ADR instrument; add on a signed manufacturing license with explicit 2026 revenue-recognition terms. Target a 6-12 month rerating on reduced revenue-timing uncertainty; exit if FY guidance is cut or the new license slips beyond year-end.
• Avoid extrapolating the current revenue run-rate into earnings models: value CWR on a probability-weighted royalty ramp beginning in 2027-29, applying a substantial execution discount until partner shipment volumes are independently disclosed.
• Watch CNA for evidence that behind-the-meter projects convert from feasibility discussions to contracted deployments. A disclosed multi-site order would validate CWR demand but is likely more material to CWR’s multiple than to CNA’s earnings.
• Use SHEL only as a liquid hydrogen-transition proxy rather than a CWR read-through; Shell’s diversified cash flows make any Ceres-related electrolyzer progress immaterial to near-term valuation.
• Set an alert on UK/EU power-to-gas spreads and natural-gas prices: sustained compression in the spread is the fastest fundamental challenge to SOFC project economics and should prompt a reduction in CWR exposure before reported milestones deteriorate.